The present study was conducted to examine alterations in plasma free amino acid concentrations induced by squat exercise and branched-chain amino acid (BCAA) supplementation in young, untrained female subjects. In the morning on the exercise session day, participants ingested drinks containing either BCAA (isoleucine : leucine : valine ϭ 1 : 2.3 : 1.2) or dextrin (placebo) at 0.1 g/kg body weight 15 min before a squat exercise session, which consisted of 7 sets of 20 squats, with 3 min intervals between sets. In the placebo trial, plasma BCAA concentrations were decreased subsequent to exercise, whereas they were significantly increased in the BCAA trial until 2 h after exercise. Marked changes in other free amino acids in response to squat exercise and BCAA supplementation were observed. In particular, plasma concentrations of methionine and aromatic amino acids were temporarily decreased in the BCAA trial, being significantly lower than those in the placebo trial. These results suggest that BCAA intake before exercise affects methionine and aromatic amino acid metabolism. Key Words squat exercise, branched-chain amino acids, plasma free amino acids, untrained young women It is well known that amino acid metabolism is affected by exercise ( 1 ). In particular, exercise has been shown to promote branched-chain amino acid (BCAA) catabolism in rats and humans ( 2 , 3 ). Therefore, the popularity of BCAAs as a supplement for people who practice sports is growing. However, despite the common use of BCAAs, little information is available with regard to the effects of BCAA intake on the concentrations of plasma components including free amino acids other than the BCAAs. In a recent study, we have found that BCAA supplementation before squat exercise noticeably suppressed the muscle pain that occurred on the next day after exercise and lasted for a few days (delayed-onset muscle soreness (DOMS)) in young, untrained women ( 4 ). In the present study, we examined alterations in the plasma concentrations of free amino acids induced by squat exercise and BCAA supplementation.
It is well known that amino acid metabolism is affected by exercise ( 1 ). In particular, exercise has been shown to promote branched-chain amino acid (BCAA) catabolism in rats and humans ( 2 , 3 ) . Therefore, the popularity of BCAAs as a supplement for people who practice sports is growing. However, despite the common use of BCAAs, little information is available with regard to the effects of BCAA intake on the concentrations of plasma components including free amino acids other than the BCAAs. In a recent study, we have found that BCAA supplementation before squat exercise noticeably suppressed the muscle pain that occurred on the next day after exercise and lasted for a few days (delayed-onset muscle soreness (DOMS)) in young, untrained women ( 4 ) . In the present study, we examined alterations in the plasma concentrations of free amino acids induced by squat exercise and BCAA supplementation.
Materials and Methods
Experiments were conducted essentially as described previously ( 4 ), except for the following points: (i) 12 young, healthy female volunteers who did not exercise in a regular basis participated in this study, (ii) the subjects ingested the test drink containing BCAA mixture or dextrin at 0.1 g/kg body weight, and (iii) blood samples were collected for preparations of plasma and serum before exercise and at several time points after exercise (see below). The compositions of the test drinks were as follows: a BCAA drink (200 mL) containing 5.5 g of a BCAA mixture (isoleucine, leucine, and valine at a ratio of 1 : 2.3 : 1.2 ( 5 )), 1 g instant green tea powder (Ajinomoto General Foods, Tokyo) and 1.2 g nonnutritive sweetener (Pal Sweet, Ajinomoto, Tokyo), and a placebo drink containing the same ingredients as the BCAA drink except for 5.5 g dextrin instead of the BCAAs ( 4 ). The age of the participants was 22.2 Ϯ 0.5 (mean Ϯ SE) y, height was 158 Ϯ 1 cm, body weight was 48.5 Ϯ 1.5 kg, and the body mass index was 19.4 Ϯ 0.5 kg/m 2 .
Since the squat exercise program used in this study is relatively safe for untrained subjects and causes DOMS ( 4 ), this exercise program was used in the present study. The experiment was conducted as a crossover design, so that each subject was tested with both BCAA and placebo drinks, separated by an 11-wk interval, as follows. During each trial, subjects were randomly divided into two groups, with half of them taking the BCAA drink E-mail: shimo@agr.nagoya-u.ac.jp and half the placebo drink. On the first day of the experiment (day 1), overnight fasted subjects reported to the laboratory at 0830 h, when the first blood collection was carried out. They were given a jelly-type food (200 g in weight containing 100 kcal from sugar) at 0900 h in order to minimize the effect of starvation on BCAA catabolism. At 0930 h, the BCAA or the placebo drink was provided to the subjects. The squat exercise session, which initiated ~15 min after ingestion of the test drink, consisted of 7 sets of 20 squats (total 140 repetitions), with squats performed every 2 s and 3-min intervals between sets. Blood was collected again right after exercise (0 h time point) and 1 and 2 h after exercise. Additional blood samples were collected at about 0830 h on the next day (day 2) and day 3 under the same conditions as on day 1. Informed written consent was obtained after the nature and possible consequences of the study were explained. The study protocol was approved by the human research review committee of the Nagoya University School of Medicine.
Plasma samples were treated for deproteinization as reported previously ( 6 ) , and free amino acid concentrations were analyzed using the automated JLC-500/V Amino Acid Analyzer (JEOL, Tokyo). The analyses of serum insulin concentrations were performed by the Special Reference Laboratories (SRL) Inc. (Tokyo).
Data are expressed as means Ϯ SE. To compare plasma amino acid concentrations over time and between tri- als, a 2-way repeated measures ANOVA was applied. The Tukey post hoc test was applied in the case of a significant F-ratio to locate specific differences. Changes over time within each trial were tested using 1-way repeated measures ANOVA. The analyses were performed using StatView 5.0 software (SAS Institute, Cary, NC) and Stat Mate III 3.14 software (ATMS, Co., Ltd., Tokyo). Differences were significant at pϽ0.05 in 2-tailed testing.
Results and Discussion
Total BCAA (the sum of isoleucine, leucine and valine) concentrations are shown in Table 1 . Alteration patterns in plasma concentrations of individual BCAAs, which will be reported elsewhere, were similar to the patterns observed for total BCAA in both placebo and BCAA trials. Plasma BCAA concentration in the placebo trial significantly decreased following the squat exercise, suggesting promoted BCAA oxidation. On the other hand, BCAA concentration peaked right after exercise and the level of the peak was 2.2-fold higher than that before exercise in the BCAA trial. In addition, BCAA levels from the time point right after exercise through 2 h post-exercise were significantly higher in the BCAA trial than those in the placebo trial at corresponding time points.
Concentrations of all amino acids other than aspartate in both trials and glutamine in the BCAA trial were significantly altered during the experiment (Table 1) . Among the altered amino acids, only the alanine concentration tended to increase after exercise in both trials. The responses of alanine to exercise and glutamine to BCAA supplementation are consistent with previous reports (7, 8) . Variation in glutamine concentration over time was not significant in the BCAA trial, and it was significantly higher in the BCAA than in the placebo trial from 0 to 2 h after exercise, indicating that the BCAA supplement suppressed the exercise-induced decreases in plasma glutamine concentrations. Plasma glutamine is known as an important substrate for immune cells (9, 10) . Therefore, BCAA supplementation before exercise may play a role in supporting the immune system, although the relation between plasma glutamine levels and exercise-induced immune suppression is still controversial (11, 12) .
Post-exercise methionine, phenylalanine, and tyrosine concentrations were markedly different between the two trials; methionine, phenylalanine, and tyrosine levels 1-2 h post-exercise were significantly lower in the BCAA than in the placebo trial. In addition, plasma tryptophan concentrations tended to decrease 1-2 h post-exercise in the BCAA trial, suggesting that BCAA ingestion affects the levels of all aromatic amino acids. Interestingly, the observed decreases in aromatic amino acids and methionine concentrations occurred after a lag time of ~1 h from the rise in the BCAA concentration. Since the serum insulin level has great effects on energy metabolism including amino acids, this hormone might be a factor influencing concentrations of plasma methionine and aromatic amino acids.
However, the insulin concentrations at each time point were not different between the BCAA and the placebo trials.
It has been reported that the branched-chain ␣-keto acid dehydrogenase complex (BCKDC, the rate-limiting enzyme in the BCAA catabolic pathway) affects methionine catabolism in the liver (13, 14) and that leucine administration activates hepatic BCKDC in rats (15) . Notwithstanding the fact that the activity level of hepatic BCKDC is markedly lower in humans than in rats (16, 17) , BCAA intake-induced upregulation in the liver BCKDC may be involved in the mechanism responsible for the decrease in plasma methionine concentration.
Decreases in the concentrations of aromatic amino acids following BCAA intake is a quite interesting outcome of this study, but the underlying factors that bring about this phenomenon remain unresolved. In fact, other studies concerning the effect of BCAA supplementation before exercise on plasma free amino acid concentrations did not show clear decreases in the levels of aromatic amino acids (7, 8) . We suppose that this discrepancy may be derived from differences in the experimental conditions such as the exercise protocol, trained/untrained subjects, and sex and age of the subjects.
It has been suggested that BCAAs are beneficial against liver diseases and hepatic encephalopathy (18) and that the decrease in the ratio of BCAA to aromatic amino acids plays a causal role in hepatic encephalopathy by increasing brain aromatic amino acid uptake (19) . It is interesting to consider, therefore, that the BCAA effect of lowering plasma aromatic amino acid concentrations observed in the present study may be related to the beneficial effect of BCAAs against hepatic encephalopathy. Further studies are required to elucidate the mechanisms that underlie the influence of BCAA supplementation on aromatic amino acid and methionine metabolism.
